Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06724523 · ClinicalTrials.gov registry record
Pre- and Post- Descriptive Data of Language Outcomes in Deaf Children
A clinical trial of Sign Language Skills, sponsored by The University of Tennessee, Knoxville.
- Active
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT06724523 is a study of Sign Language Skills that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 160 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06724523, a study of Sign Language Skills, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.
- ACTIVE NOT RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Deaf children between ages of 4-10 will provide pre and post data by responding to three prompts in sign language and written language at the beginning and end of a year. This data will provide information on the developmental trends and characteristics of deaf children who will receive SISI the following year.
Conditions Studied
Interventions
- BEHAVIORAL Business-as-usual instruction
Study Locations (1)
Tennessee
- University of Tennessee, Knoxville - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2025-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06724523
The ClinicalTrials.gov registry entry for NCT06724523 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Tennessee, Knoxville, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sign Language Skills appearing as the primary indexed condition, and to 1 intervention - of which Business-as-usual instruction is the first listed.
NCT06724523 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT06724523 about?
NCT06724523 is a clinical study titled "Pre- and Post- Descriptive Data of Language Outcomes in Deaf Children". Deaf children between ages of 4-10 will provide pre and post data by responding to three prompts in sign language and written language at the beginning and end of a year. This data will provide information on the developmental trends and characteristics of deaf children who will receive SISI the fol...
What is the current status of trial NCT06724523?
This trial is currently active not recruiting. The enrollment target is 160 participants. The study started on 2024-08-01. Estimated completion is 2025-07-30.
What conditions does trial NCT06724523 study?
This clinical trial studies the following conditions: Sign Language Skills.
What interventions are being tested in trial NCT06724523?
The interventions under investigation include: Business-as-usual instruction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06724523?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06724523 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sign Language Skills
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.